Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells. (1st September 2016)
- Record Type:
- Journal Article
- Title:
- Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells. (1st September 2016)
- Main Title:
- Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells
- Authors:
- Yang, Xiaoyan
Sheng, Ye
Ray, Animikh
Shah, Sujay J.
Trinh, Hoang M.
Pal, Dhananjay
Mitra, Ashim K. - Abstract:
- Abstract: Purpose : The objective of this study is to investigate cellular uptake of prodrug-loaded nanoparticle (NP). Another objective is to study bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir (GCV) including L-Val-L-Val-GCV (LLGCV), L-Val-D-Val-GCV (LDGCV) and d -Val-l -Val-GCV (DLGCV) in human corneal epithelial cell (HCEC) model. Methods : Poly(D, L -lactic- co -glycolic acid) (PLGA) NP encapsulating prodrugs of GCV were formulated under a double emulsion method. Fluorescein isothiocyanate isomer–PLGA conjugates were synthesized to fabricate biocompatible fluorescent PLGA NP. Intracellular uptake of FITC-labeled NP was visualized by a fluorescent microscope in HCEC cells. Results : Fluorescent PLGA NP and non-fluorescent NP display similar hydrodynamic diameter in the range of 115–145 nm with a narrow particle size distribution and zeta potentials around −13 mV. Both NP types showed identical intracellular accumulation in HCEC cells. Maximum uptake (around 60%) was noted at 3 h for NP. Cellular uptake and intracellular accumulation of prodrugs are significantly different among three stereoisomeric dipeptide prodrugs. The microscopic images show that NPs are avidly internalized by HCEC cells and distributed throughout the cytoplasm instead of being localized on the cell surface. Following cellular uptake, prodrugs released from NP gradually bioreversed into parent drug GCV. LLGCV showed the highest degradation rate, followed by LDGCV and DLGCV.Abstract: Purpose : The objective of this study is to investigate cellular uptake of prodrug-loaded nanoparticle (NP). Another objective is to study bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir (GCV) including L-Val-L-Val-GCV (LLGCV), L-Val-D-Val-GCV (LDGCV) and d -Val-l -Val-GCV (DLGCV) in human corneal epithelial cell (HCEC) model. Methods : Poly(D, L -lactic- co -glycolic acid) (PLGA) NP encapsulating prodrugs of GCV were formulated under a double emulsion method. Fluorescein isothiocyanate isomer–PLGA conjugates were synthesized to fabricate biocompatible fluorescent PLGA NP. Intracellular uptake of FITC-labeled NP was visualized by a fluorescent microscope in HCEC cells. Results : Fluorescent PLGA NP and non-fluorescent NP display similar hydrodynamic diameter in the range of 115–145 nm with a narrow particle size distribution and zeta potentials around −13 mV. Both NP types showed identical intracellular accumulation in HCEC cells. Maximum uptake (around 60%) was noted at 3 h for NP. Cellular uptake and intracellular accumulation of prodrugs are significantly different among three stereoisomeric dipeptide prodrugs. The microscopic images show that NPs are avidly internalized by HCEC cells and distributed throughout the cytoplasm instead of being localized on the cell surface. Following cellular uptake, prodrugs released from NP gradually bioreversed into parent drug GCV. LLGCV showed the highest degradation rate, followed by LDGCV and DLGCV. Conclusion : LLGCV, LDGCV and DLGCV released from NP exhibited superior uptake and bioreversion in corneal cells. … (more)
- Is Part Of:
- Drug delivery. Volume 23:Number 7(2016:Oct.)
- Journal:
- Drug delivery
- Issue:
- Volume 23:Number 7(2016:Oct.)
- Issue Display:
- Volume 23, Issue 7 (2016)
- Year:
- 2016
- Volume:
- 23
- Issue:
- 7
- Issue Sort Value:
- 2016-0023-0007-0000
- Page Start:
- 2532
- Page End:
- 2540
- Publication Date:
- 2016-09-01
- Subjects:
- Bioconversion -- ganciclovir prodrugs -- HSV-1 keratitis -- PLGA nanoparticles -- uptake
Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/10717544.2015.1023384 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21977.xml